| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.4 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |